Hisashi Yamanaka
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 321 publications
Beyond evidence supremacy: Reclaiming the Clinician's role through the integration of structural and existential approaches in daily practice.
Journal: Modern rheumatology
Published: January 20, 2026
Efficacy and Safety of Tofacitinib and Adalimumab in Rheumatoid Arthritis by Body Mass Index-Normalized Methotrexate Dose: A Post Hoc Analysis.
Journal: Rheumatology and therapy
Published: September 06, 2025
Factors associated with treatment discontinuation and age-stratified safety of abatacept in Japanese patients with rheumatoid arthritis: 5-year results of the ORIGAMI study.
Journal: Modern rheumatology
Published: August 14, 2025
Response to the Letter to the Editor: "Rheumatoid arthritis and subsequent fracture risk".
Journal: Journal of bone and mineral metabolism
Published: August 04, 2025
Letter to the Editor Regarding "Evaluation of VTE, MACE, and Serious Infections Among Patients with RA Treated with Baricitinib Compared to TNFi: A Multi-Database Study of Patients in Routine Care Using Disease Registries and Claims Databases".
Journal: Rheumatology and therapy
Published: July 29, 2025
Increasing fracture incidence over 13 years in patients with rheumatoid arthritis from the IORRA cohort.
Journal: Journal of bone and mineral metabolism
Published: January 02, 2025
Laboratory markers predicting tofacitinib efficacy in Japanese patients with rheumatoid arthritis: A pooled analysis of Phase 2/3 randomised controlled clinical trials.
Journal: Modern rheumatology
Published: September 03, 2024
Higher risk of poor functional outcome and unfavourable clinical events for late-onset rheumatoid arthritis: results from the IORRA cohort.
Journal: Rheumatology (Oxford, England)
Published: June 10, 2024
Methotrexate, Tofacitinib, and Biologic Disease-Modifying Antirheumatic Drug Safety and Effectiveness Among Patients with Rheumatoid Arthritis in Japan: CorEvitas Registry Observational Study.
Journal: Rheumatology and therapy
Published: April 20, 2024
Factors contributing to the improvement in Japanese Health Assessment Questionnaire after 3 years of treatment with abatacept in biologic-naïve rheumatoid arthritis patients: Interim results of a long-term, observational, multicentre study in Japan (ORIGAMI).
Journal: Modern rheumatology
Published: February 29, 2024
Incidence of Malignancies and the Association with Biological Disease-Modifying Antirheumatic Drugs in Japanese Patients with Rheumatoid Arthritis: A Time-Dependent Analysis from the IORRA Patient Registry.
Journal: Rheumatology and therapy
Published: February 22, 2024
Last Updated: 09/26/2026